- US12240838utility2025Inhibiting Agents for Bruton's Tyrosine Kinase0 cites
- US12233248utility2025Smart Injector0 cites
- US12180205utility2024O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase Inhibitors0 cites
- US12162952utility2024Human-derived Anti-(poly-ga) Dipeptide Repeat (DPR) Antibody0 cites
- US12105090utility2024Methods of Treating a Multiple Sclerosis Patient with Anti-vla-4 Therapy0 cites
- US12091662utility2024Compositions for Modulating Tau Expression0 cites
- US12066442utility2024Method of Assessing Risk of PML0 cites
- US12037398utility2024Anti-vla-4 Antibodies Having Reduced Effector Function0 cites
- US12031990utility2024Method of Assessing Risk of PML0 cites
- US12018046utility2024Use of Cation-exchange Chromatography in the Flow-through Mode to Enrich Post-translational Modifications0 cites
- US12013403utility2024Compositions and Methods for Detection of SMN Protein in a Subject and Treatment of a Subject0 cites
- US11999715utility2024ASK1 Inhibiting Agents0 cites
- US11897898utility2024Pyridine Macrocycle Compounds as ASK1 Inhibiting Agents0 cites
- US11884737utility2024Treatment of Autoimmune Disorders with CD154 Antibodies0 cites
- US11858926utility2024Inhibiting Agents for Bruton's Tyrosine Kinase0 cites
- US11857349utility2024Apparatus and Related Method to Facilitate Test via a Computing Device0 cites
- US11854198utility2023Methods for Improved Measurements of Brain Volume and Changes in Brain Volume0 cites
- US11834491utility2023Arginine-free Tnfr:fc-fusion Polypeptide Compositions0 cites
- US11827702utility2023Anti-transferrin Receptor Antibodies and Uses Thereof0 cites